Expert consensus on perioperative nursing care for myasthenia gravis patients undergoing thymectomy_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

DONG Huimin ¹ , ZHOU Ting ² , ZHONG Yingmei ³ , LI Wei ⁴ , LI Xiaoyan ⁵ ,  ZHANG Chunfang ⁵ ,  QI Guoyan ¹ ,  LIU Yangchun ³ , Myasthenia Gravis Union of China Union of China , Committee of Integrated Rehabilitation for Thymic Tumors of China Anti-Cancer Association , Myasthenia Gravis Group of the Thoracic Surgery Committee of the Cross-Strait Medical and Health Exchange Association—Consensus Drafting Expert Panel

1. Myasthenia Gravis Diagnosis and Treatment Center, Shijiazhuang People's Hospital, Shijiazhuang, 050000, P. R. China;
2. Department of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, Beijing, 100730, P. R. China;
3. Department of Thoracic Surgery, Jiangxi Provincial People's Hospital, Nanchang, 330000, P. R. China;
4. Department of Thoracic Surgery, Union Hospital Affiliated to Fujian Medical University, Fuzhou, 350000, P. R. China;
5. Department of Thoracic Surgery, Xiangya Hospital of Central South University, Changsha, 410000, P. R. China;

Corresponding?author：

ZHANG Chunfang, Email: zhcf3801@csu.edu.cn; QI Guoyan, Email: zzjwlsys@163.com; LIU Yangchun, Email: lyc195411@sina.com

Keywords：

Myasthenia gravis; thymectomy; nursing care; nutritional support; airway management; expert consensus

DOI：

10.7507/1007-4848.202510077

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Myasthenia gravis is an autoimmune disorder characterized by impaired neuromuscular transmission. Thymectomy is one of the therapeutic options for acetylcholine receptor antibody-positive myasthenia gravis patients. The quality of perioperative care is directly associated with surgical safety and patient outcomes. However, there is currently a lack of specialized nursing consensus or guidelines specifically addressing the care of these patients domestically or internationally. To promote the standardization and normalization of perioperative nursing care for myasthenia gravis patients undergoing thymectomy and to ensure treatment efficacy, a panel of 57 experts from relevant fields was convened. Based on evidence-based medicine and clinical practice experience, discussions were held on various aspects including condition assessment, nutritional support, medication management, and airway care, resulting in a consensus with 18 final recommendations by using the Delphi method through two rounds of expert consultation. This consensus aims to provide a scientific reference for the perioperative nursing care of myasthenia gravis patients undergoing thymectomy.

1.	Salari N, Fatahi B, Bartina Y, et al. Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis. J Transl Med, 2021, 19(1): 516.
2.	Chen J, Tian DC, Zhang C, et al. Incidence, mortality, and economic burden of myasthenia gravis in China: a nationwide population-based study. Lancet Reg Health West Pac, 2020, 5: 100063.
3.	Cheng M, Anderson MS. Thymic tolerance as a key brake on autoimmunity. Nat Immunol, 2018, 19(7): 659-664.
4.	Marx A, Pfister F, Schalke B, et al. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev, 2013, 12(9): 875-884.
5.	Ambrogi V, Mineo TC. Active ectopic thymus predicts poor outcome after thymectomy in class Ⅲ myasthenia gravis. J Thorac Cardiovasc Surg, 2012, 143(3): 601-606.
6.	Chen K, Li Y, Yang H. Poor responses and adverse outcomes of myasthenia gravis after thymectomy: predicting factors and immunological implications. J Autoimmun, 2022, 132: 102895.
7.	Machens A, Emsk?tter T, Busch C, et al. Postoperative infection after transsternal thymectomy for myasthenia gravis: a retrospective analysis of 125 cases. Surg Today, 1998, 28(8): 808-810.
8.	中華醫學會神經病學分會神經免疫學組. 中國重癥肌無力診斷和治療指南(2025版). 中華神經科雜志, 2025, 58(7): 721-741.Chinese Neurological Association Neuroimmunology Group. Chinese guidelines for the diagnosis and treatment of myasthenia gravis (2025 edition). Chin J Neurol, 2025, 58(7): 721-741.
9.	譚群友, 陶紹霖, 劉寶東, 等. 重癥肌無力外科治療中國臨床專家共識. 中國胸心血管外科臨床雜志, 2022, 29(5): 529-541.Tan QY, Tao SL, Liu BD, et al. Chinese clinical expert consensus on surgical treatment of myasthenia gravis. Chin J Clin Thorac Cardiovasc Surg, 2022, 29(5): 529-541.
10.	Narayanaswami P, Sanders DB, Wolfe G, et al. International consensus guidance for management of myasthenia gravis: 2020 update. Neurology, 2021, 96(3): 114-122.
11.	Wiendl H, Abicht A, Chan A, et al. Guideline for the management of myasthenic syndromes. Ther Adv Neurol Disord, 2023, 16: 71472968.
12.	羅蘇珊, 周昊, 岳耀先, 等. 重癥肌無力危象前狀態管理專家共識(2024). 中國臨床神經科學, 2024, 32(3): 241-251.Luo SS, Zhou H, Yue YX, et al. Expert consensus on the management of myasthenia gravis pre-crisis state (2024). Chin J Clin Neurosci, 2024, 32(3): 241-251.
13.	許雅芳, 薄琳, 邢介霞, 等. 成人全身型重癥肌無力患者全病程護理專家共識(2024). 中國臨床神經科學, 2024, 32(5): 577-586.Xu YF, Bo L, Xing JX, et al. Expert consensus on whole-course nursing for adult patients with generalized myasthenia gravis (2024). Chin J Clin Neurosci, 2024, 32(5): 577-586.
14.	中國醫師協會醫學機器人醫師分會胸外科專業委員會籌備組, 譚群友, 陶紹霖, 等. 機器人輔助縱隔腫瘤手術中國專家共識(2019版). 中國胸心血管外科臨床雜志, 2020, 27(2): 117-125.Thoracic Surgery Professional Committee Preparatory Group of Medical Robot Branch of Chinese Medical Doctor Association, Tan QY, Tao SL, et al. Chinese expert consensus on robot-assisted mediastinal tumor surgery (2019 edition). Chin J Clin Thorac Cardiovasc Surg, 2020, 27(2): 117-125.
15.	Liu C, Liu P, Zhang XJ, et al. Assessment of the risks of a myasthenic crisis after thymectomy in patients with myasthenia gravis: a systematic review and meta-analysis of 25 studies. J Cardiothorac Surg, 2020, 15(1): 270.
16.	范沁琳, 袁馳, 靳英輝, 等. 基于RIGHT和ACCORD清單的專家共識規范化報告. 中國胸心血管外科臨床雜志, 2025, 32(7): 930-939.Fan QL, Yuan C, Jin YH, et al. Standardized reporting of expert consensus based on the RIGHT and ACCORD checklists. Chin J Clin Thorac Cardiovasc Surg, 2025, 32(7): 930-939.
17.	Prado MJ, Adiao KJ. Acetylcholinesterase inhibitors in myasthenic crisis: a systematic review of observational studies. Neurocrit Care, 2021, 35(2): 528-544.
18.	U?ak MN, Ar?t?c? ?G. Myasthenia gravis and nutrition. Front Nutr, 2025, 12: 1600508.
19.	王巖, 曹玉, 殷金環, 等. 胸腺瘤術后患者預后營養指數與總生存率的相關性. 腫瘤防治研究, 2021, 48(2): 140-144.Wang Y, Cao Y, Yin JH, et al. Correlation between prognostic nutritional index and overall survival rate in patients after thymoma surgery. Cancer Res Prev Treat, 2021, 48(2): 140-144.
20.	Kondrup J, Allison SP, Elia M, et al. ESPEN guidelines for nutrition screening 2002. Clin Nutr, 2003, 22(4): 415-421.
21.	中華醫學會腸外腸內營養學分會. 成人圍手術期營養支持指南. 中華外科雜志, 2016, 54(9): 641-657.Chinese Society for Parenteral and Enteral Nutrition. Guidelines for nutritional support in the perioperative period for adults. Chin J Surg, 2016, 54(9): 641-657.
22.	陳梁. 免疫營養劑對胸腺瘤伴重癥肌無力術后并發癥的影響. 吉林大學, 2018.Chen L. The effect of immunonutritional agents on postoperative complications of thymoma with myasthenia gravis. Jilin University, 2018.
23.	Probst P, Ohmann S, Klaiber U, et al. Meta-analysis of immunonutrition in major abdominal surgery. Br J Surg, 2017, 104(12): 1594-1608.
24.	邢娟, 章仲恒, 柯路, 等. 2017年中國ICU患者營養治療實施狀況橫斷面調查. 解放軍醫學雜志, 2019, 44(5): 388-393.Xing J, Zhang ZH, Ke L, et al. A cross-sectional survey on the implementation status of nutritional therapy for ICU patients in China in 2017. Med J Chin PLA, 2019, 44(5): 388-393.
25.	Bolgeo T, Di Matteo R, Gallione C, et al. Intragastric prepyloric enteral nutrition, bolus vs continuous in the adult patient: a systematic review and meta-analysis. Nutr Clin Pract, 2022, 37(4): 762-772.
26.	Wu JY, Liu MY, Liu TH, et al. Clinical efficacy of enteral nutrition feeding modalities in critically ill patients: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Nutr, 2023, 77(11): 1026-1033.
27.	賴敏華, 朱曼瑜, 林麗霞, 等. 重癥鼻飼病人防誤吸的最佳證據實踐研究. 循證護理, 2024, 10(15): 2666-2672.Lai MH, Zhu MY, Lin LX, et al. Best evidence practice study on preventing aspiration in severe nasal feeding patients. Chin Evid Based Nurs, 2024, 10(15): 2666-2672.
28.	Hu K, Adachi JD. Glucocorticoid induced osteoporosis. Expert Rev Endocrinol Metab, 2019, 14(4): 259-266.
29.	張冰清, 曾學軍. 硫唑嘌呤相關白細胞減少的研究進展. 中華內科雜志, 2018, 57(7): 535-538.Zhang BQ, Zeng XJ. Research advances in azathioprine-associated leukopenia. Chin J Intern Med, 2018, 57(7): 535-538.
30.	Venkataramanan R, Swaminathan A, Prasad T, et al. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet, 1995, 29(6): 404-430.
31.	Abushammala I. Tacrolimus and herbs interactions: a review. Pharmazie, 2021, 76(10): 468-472.
32.	林良沫, 黃春新. 番石榴致環孢素血藥濃度升高患者的藥學監護. 中國醫院用藥評價與分析, 2015, 15(8): 1117-1119.Lin LM, Huang CX. Pharmaceutical care for a patient with elevated cyclosporine blood concentration due to guava. Chin J Drug Eval Anal, 2015, 15(8): 1117-1119.
33.	Alipour-Faz A, Shojaei M, Peyvandi H, et al. A comparison between IVIG and plasma exchange as preparations before thymectomy in myasthenia gravis patients. Acta Neurol Belg, 2017, 117(1): 245-249.
34.	Orbach H, Katz U, Sherer Y, et al. Intravenous immunoglobulin: adverse effects and safe administration. Clin Rev Allergy Immunol, 2005, 29(3): 173-184.
35.	Imbach P, Barandun S, D'Apuzzo V, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet, 1981, 1(8232): 1228-1231.
36.	Howard JJ, Bril V, Vu T, et al. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial. Lancet Neurol, 2021, 20(7): 526-536.
37.	Ma J, Zhang H, Zhao J, et al. Efgartigimod versus intravenous immunoglobulin in the treatment of patients with impending myasthenic crisis. Sci Rep, 2024, 14(1): 28394.
38.	洪苗, 蔡東東, 魏彩輝, 等. 血漿置換治療胸腺瘤相關重癥肌無力的療效分析. 中國輸血雜志, 2025, 38(9): 1188-1194.Hong M, Cai DD, Wei CH, et al. Efficacy analysis of plasma exchange in the treatment of thymoma-associated myasthenia gravis. Chin J Blood Transfus, 2025, 38(9): 1188-1194.
39.	Mahmoud SH, Buhler J, Chu E, et al. Drug dosing in patients undergoing therapeutic plasma exchange. Neurocrit Care, 2021, 34(1): 301-311.
40.	朱淑華, 龔德華. 血漿置換臨床實踐中的技術要點. 中國血液凈化, 2021, 20(5): 289-293.Zhu SH, Gong DH. Technical key points in the clinical practice of plasma exchange. Chin J Blood Purif, 2021, 20(5): 289-293.
41.	Gashti CN, Andreoli DC, Patel D. Membrane-based therapeutic plasma exchange (mTPE): technical and clinical experience. J Clin Apher, 2018, 33(1): 38-45.
42.	戴兵, 曾力, 張雷, 等. 器官移植相關的血液凈化技術規范(2019版). 器官移植, 2020, 11(2): 208-221.Dai B, Zeng L, Zhang L, et al. Technical specifications for blood purification related to organ transplantation (2019 edition). Organ Transplant, 2020, 11(2): 208-221.
43.	程冰, 施文麗, 李晨陽, 等. 肝衰竭患者人工肝血漿置換護理的證據總結. 中國護理管理, 2025, 25(6): 901-907.Cheng B, Shi WL, Li CY, et al. Evidence summary for nursing care of liver failure patients undergoing artificial liver plasma exchange. Chin J Nurs Manag, 2025, 25(6): 901-907.
44.	徐萍, 于笑霞, 劉俊蘭. 198例雙重濾過血漿置換不良事件的安全性分析及護理對策. 風濕病與關節炎, 2014, 3(6): 32-34.Xu P, Yu XX, Liu JL. Safety analysis and nursing countermeasures for adverse events in 198 cases undergoing double filtration plasmapheresis. Rheumatism Arthritis, 2014, 3(6): 32-34.
45.	歐昶毅, 冉昊, 邱力, 等. 127例次重癥肌無力患者危象前狀態相關因素的分析. 中華醫學雜志, 2017, 97(37): 2884-2889.Ou CY, Ran H, Qiu L, et al. Analysis of related factors for pre-crisis state in 127 episodes of myasthenia gravis patients. Natl Med J China, 2017, 97(37): 2884-2889.
46.	Chen P, Bao F, Pompeo E, et al. Summary of the best evidence for the prevention and management of myasthenic crisis after thymectomy. Gland Surg, 2024, 13(4): 540-551.
47.	曠振宇, 朱泉, 盧禮卿, 等. 胸腺切除治療重癥肌無力研究進展. 中國臨床新醫學, 2025, 18(10): 1080-1085.Kuang ZY, Zhu Q, Lu LQ, et al. Research progress in thymectomy for myasthenia gravis. Chin J Clin New Med, 2025, 18(10): 1080-1085.
48.	Hoffacker V, Schultz A, Tiesinga JJ, et al. Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood, 2000, 96(12): 3872-3879.
49.	王振榮. 胸腺瘤術后肺部感染的危險因素分析與個體化護理. 遼寧醫學雜志, 2022, 36(5): 92-96.Wang ZR. Analysis of risk factors and individualized nursing for postoperative pulmonary infection in patients with thymoma. Med J Liaoning, 2022, 36(5): 92-96.
50.	韓丁培, 嚴越, 曹羽欽, 等. 加速康復外科理念在胸外科臨床實踐指導的瑞金醫院專家共識. 山東大學學報(醫學版), 2022, 60(11): 11-16.Han DP, Yan Y, Cao YQ, et al. Ruijin Hospital expert consensus on the guidance of enhanced recovery after surgery in thoracic surgery clinical practice. J Shandong Univ Health Sci, 2022, 60(11): 11-16.
51.	Sheikh S, Alvi U, Soliven B, et al. Drugs that induce or cause deterioration of myasthenia gravis: an update. J Clin Med, 2021, 10(7): 1537.
52.	崔新征, 張清勇, 馬文強, 等. 快速康復外科在重癥肌無力外科治療中的應用. 中國實用神經疾病雜志, 2020, 23(5): 432-435.Cui XZ, Zhang QY, Ma WQ, et al. Application of enhanced recovery after surgery in the surgical treatment of myasthenia gravis. Chin J Pract Nerv Dis, 2020, 23(5): 432-435.
53.	Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs, 2005, 14(7): 798-804.
54.	Hawker GA, Mian S, Kendzerska T, et al. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken), 2011, 63(Suppl 11): S240-S252.
55.	Castarlenas E, Sánchez-Rodríguez E, Vega RL, et al. Agreement between verbal and electronic versions of the numerical rating scale (NRS-11) when used to assess pain intensity in adolescents. Clin J Pain, 2015, 31(3): 229-234.
56.	王敏, 曾蘇華, 杜韞雨, 等. 護士驅動多學科協作下食管癌根治術病人圍術期疼痛管理方案的構建及應用. 護理研究, 2024, 38(20): 3715-3720.Wang M, Zeng SH, Du YY, et al. Construction and application of a perioperative pain management program for patients undergoing radical esophagectomy under nurse-led multidisciplinary collaboration. Chin Nurs Res, 2024, 38(20): 3715-3720.
57.	Iorio R. Myasthenia gravis: the changing treatment landscape in the era of molecular therapies. Nat Rev Neurol, 2024, 20(2): 84-98.
58.	Luo F, Annane D, Orlikowski D, et al. Invasive versus non-invasive ventilation for acute respiratory failure in neuromuscular disease and chest wall disorders. Cochrane Database Syst Rev, 2017, 12(12): D8380.
59.	劉蘭星, 康麗萍, 嚴玉英, 等. 重癥肌無力危象無創通氣應用的研究進展. 中華神經醫學雜志, 2021, 20(8): 859-863.Liu LX, Kang LP, Yan YY, et al. Research progress on the application of non-invasive ventilation in myasthenia gravis crisis. Chin J Neurol Med, 2021, 20(8): 859-863.
60.	Munshi L, Mancebo J, Brochard LJ. Noninvasive respiratory support for adults with acute respiratory failure. N Engl J Med, 2022, 387(18): 1688-1698.
61.	羅蘇珊, 奚才華, 楊磊, 等. 重癥肌無力危象多學科協作的華山經驗. 中國臨床神經科學, 2023, 31(5): 550-557.Luo SS, Xi CH, Yang L, et al. The Huashan model of multidisciplinary collaboration for myasthenia gravis crisis. Chin J Clin Neurosci, 2023, 31(5): 550-557.
62.	Sun Q, Shan F, Dong H, et al. Predictive value of ultrasonic diaphragm thickening fraction on successful weaning for patients with myasthenia gravis crisis. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2017, 29(7): 619-623.
63.	Marois C, Combes A, Bouguerra M, et al. Weaning from mechanical ventilation in myasthenic crisis according to WEAN safe: most patients experience intermediate or prolonged weaning with no differences between early and late-onset compared to very-late onset myasthenia gravis. Ann Intensive Care, 2025, 15(1): 95.
64.	趙海平, 王榮榮. 神經重癥氣管切開患者氣道功能康復與管理專家共識(2024). 中國康復理論與實踐, 2024, 30(8): 869-881.Zhao HP, Wang RR. Expert consensus on airway function rehabilitation and management for tracheotomized patients with neurocritical illness (2024). Chin J Rehabil Theory Pract, 2024, 30(8): 869-881.
65.	Lionello F, Lapia F, Molena B, et al. The safety of a high-flow nasal cannula in neuromuscular disease patients with acute respiratory failure: a retrospective case-series study. J Clin Med, 2023, 12(18): 6061.
66.	梁艷春, 蔡繼紅. 重癥肌無力患者癥狀負擔及心理體驗質性研究的Meta整合. 中華現代護理雜志, 2023, 29(27): 3662-3669.Liang YC, Cai JH. A meta-synthesis of qualitative research on symptom burden and psychological experience in patients with myasthenia gravis. Chin J Mod Nurs, 2023, 29(27): 3662-3669.
67.	Luo S, Xiong Y, Song Z, et al. A cross-sectional study on fear of progression in patients with myasthenia gravis. Sci Rep, 2025, 15(1): 26181.
68.	王悅, 劉飛, 朱丹, 等. 乳腺癌患者同伴教育者總體幸福感現狀及影響因素研究. 中華護理雜志, 2024, 59(2): 191-197.Wang Y, Liu F, Zhu D, et al. Status and influencing factors of general well-being among peer educators in breast cancer patients. Chin J Nurs, 2024, 59(2): 191-197.
69.	邵紅濤, 任桂琴, 丁曉茜, 等. 正念冥想對走神的影響及其作用機制. 心理科學進展, 2023, 31(12): 2368-2379.Shao HT, Ren GQ, Ding XQ, et al. The influence of mindfulness meditation on mind wandering and its underlying mechanisms. Adv Psychol Sci, 2023, 31(12): 2368-2379.
70.	Marvin S, Thibeault SL. Predictors of aspiration and silent aspiration in patients with new tracheostomy. Am J Speech Lang Pathol, 2021, 30(6): 2554-2560.
71.	Benjapornlert P, Kagaya H, Inamoto Y, et al. The effect of reclining position on swallowing function in stroke patients with dysphagia. J Oral Rehabil, 2020, 47(9): 1120-1128.
72.	中國康復醫學會吞咽障礙康復專業委員會. 中國吞咽障礙康復管理指南(2023版). 中華物理醫學與康復雜志, 2023, 45(12): 1057-1072.Swallowing Disorders Rehabilitation Committee of Chinese Association of Rehabilitation Medicine. Chinese guidelines for rehabilitation management of swallowing disorders (2023 edition). Chin J Phys Med Rehabil, 2023, 45(12): 1057-1072.
73.	Miao P, Zhang Y, Zhong A. Risk factors of aspiration occurrence with different feeding patterns in elderly intensive care unit patients: a cross-sectional study. J Thorac Dis, 2023, 15(5): 2585-2600.
74.	馬璐璐, 黃宇光. 胸腔鏡胸腺腫瘤切除術膈神經損傷導致低氧血癥: 2例病例報告和文獻綜述. 中華醫學雜志, 2020, 35(2): 191-194.Ma LL, Huang YG. Hypoxemia due to phrenic nerve injury after video-assisted thoracoscopic thymectomy: a case report of two patients and literature review. Chin Med Sci J, 2020, 35(2): 191-194.
75.	馮勇, 宋世源, 王林琳, 等. 胸腺瘤切除伴膈神經離斷后重癥肌無力危象前狀態診治一例. 中國臨床新醫學, 2025, 18(10): 1169-1171.Feng Y, Song SY, Wang LL, et al. Diagnosis and treatment of myasthenia gravis pre-crisis state after thymoma resection with phrenic nerve transection: a case report. Chin J Clin New Med, 2025, 18(10): 1169-1171.
76.	盧靜, 張永利. ICU危重癥患者膈肌功能障礙研究進展. 中國急救醫學, 2025, 45(2): 171-178.Lu J, Zhang YL. Research progress in diaphragmatic dysfunction in critically ill ICU patients. Chin J Crit Care Med, 2025, 45(2): 171-178.
77.	Mendoza M, Tran C, Bril V, et al. Patient-acceptable symptom states in myasthenia gravis. Neurology, 2020, 95(12): e1617-e1628.
78.	皮紅英, 高遠, 候惠如, 等. 老年人跌倒風險綜合管理專家共識. 中華保健醫學雜志, 2022, 24(6): 439-441.Pi HY, Gao Y, Hou HR, et al. Expert consensus on comprehensive management of fall risk in older adults. Chin J Health Care Med, 2022, 24(6): 439-441.
79.	Schoberer D, Breimaier HE, Zuschnegg J, et al. Fall prevention in hospitals and nursing homes: clinical practice guideline. Worldviews Evid Based Nurs, 2022, 19(2): 86-93.
80.	謝芳菲, 李雙玲, 王春梅. ICU危重患者靜脈血栓栓塞癥預防策略. 基礎醫學與臨床, 2024, 44(7): 906-911.Xie FF, Li SL, Wang CM. Prevention strategies for venous thromboembolism in critically ill ICU patients. Basic Clin Med, 2024, 44(7): 906-911.
81.	李夢婷, 楊華, 郭文進. 基于Caprini風險評估量表構建重癥監護病房患者深靜脈血栓形成的預測模型. 浙江臨床醫學, 2024, 26(7): 977-979.Li MT, Yang H, Guo WJ. Development of a prediction model for deep vein thrombosis in intensive care unit patients based on the Caprini risk assessment scale. Zhejiang Clin Med J, 2024, 26(7): 977-979.
82.	周鑫飛, 嚴靜. 靜脈血栓栓塞癥風險評估模型在重癥監護室中的應用. 心腦血管病防治, 2022, 22(6): 66-70.Zhou XF, Yan J. Application of venous thromboembolism risk assessment models in the intensive care unit. Prev Treat Card-Cereb Vasc Dis, 2022, 22(6): 66-70.
83.	Corrado B, Giardulli B, Costa M. Evidence-based practice in rehabilitation of myasthenia gravis. A systematic review of the literature. J Funct Morphol Kinesiol, 2020, 5(4): 71.
84.	蔣琪霞, 劉國幀, 朱玉玲, 等. Braden量表診斷老年人壓力性損傷的適用性和最佳界值的多中心研究. 中華護理雜志, 2023, 58(4): 440-445.Jiang QX, Liu GZ, Zhu YL, et al. Applicability and optimal cutoff value of the Braden Scale for diagnosing pressure injury in older adults: a multicenter study. Chin J Nurs, 2023, 58(4): 440-445.
85.	Tescher A, Deppisch M, Munro C, et al. Perioperative pressure injury prevention: National Pressure Injury Advisory Panel root cause analysis toolkit 3. 0. J Wound Care, 2022, 31(Sup12): S4-S9.
86.	劉鳴, 崔麗英, 謝鵬, 等. 神經內科學(第3版/研究生). 北京: 人民衛生出版社, 2021: 342.Liu M, Cui LY, Xie P, et al. Neurology (3rd ed., For Postgraduates). Beijing: People’s Medical Publishing House, 2021.
87.	Wang S, Zhu M, Dong J, et al. Perioperative safety and efficacy of efgartigimod for thymoma-associated myasthenia gravis: a prospective, multicenter, phase II clinical trial. J Thorac Oncol, 2025, 20(8): 1120-1130.
88.	蔡崢, 丁曉璐, 郁雯佳. 靈芪參口服液聯合八段錦對脾腎氣虛證老年肌少癥患者的臨床療效. 中成藥, 2025, 47(8): 2822-2825.Cai Z, Ding XL, Yu WJ. Clinical efficacy of Lingqi Shen Oral Liquid combined with Baduanjin exercise on elderly patients with sarcopenia of spleen-kidney qi deficiency syndrome. Chin Tradit Pat Med, 2025, 47(8): 2822-2825.

1. Salari N, Fatahi B, Bartina Y, et al. Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis. J Transl Med, 2021, 19(1): 516.
2. Chen J, Tian DC, Zhang C, et al. Incidence, mortality, and economic burden of myasthenia gravis in China: a nationwide population-based study. Lancet Reg Health West Pac, 2020, 5: 100063.
3. Cheng M, Anderson MS. Thymic tolerance as a key brake on autoimmunity. Nat Immunol, 2018, 19(7): 659-664.
4. Marx A, Pfister F, Schalke B, et al. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev, 2013, 12(9): 875-884.
5. Ambrogi V, Mineo TC. Active ectopic thymus predicts poor outcome after thymectomy in class Ⅲ myasthenia gravis. J Thorac Cardiovasc Surg, 2012, 143(3): 601-606.
6. Chen K, Li Y, Yang H. Poor responses and adverse outcomes of myasthenia gravis after thymectomy: predicting factors and immunological implications. J Autoimmun, 2022, 132: 102895.
7. Machens A, Emsk?tter T, Busch C, et al. Postoperative infection after transsternal thymectomy for myasthenia gravis: a retrospective analysis of 125 cases. Surg Today, 1998, 28(8): 808-810.
8. 中華醫學會神經病學分會神經免疫學組. 中國重癥肌無力診斷和治療指南(2025版). 中華神經科雜志, 2025, 58(7): 721-741.Chinese Neurological Association Neuroimmunology Group. Chinese guidelines for the diagnosis and treatment of myasthenia gravis (2025 edition). Chin J Neurol, 2025, 58(7): 721-741.
9. 譚群友, 陶紹霖, 劉寶東, 等. 重癥肌無力外科治療中國臨床專家共識. 中國胸心血管外科臨床雜志, 2022, 29(5): 529-541.Tan QY, Tao SL, Liu BD, et al. Chinese clinical expert consensus on surgical treatment of myasthenia gravis. Chin J Clin Thorac Cardiovasc Surg, 2022, 29(5): 529-541.
10. Narayanaswami P, Sanders DB, Wolfe G, et al. International consensus guidance for management of myasthenia gravis: 2020 update. Neurology, 2021, 96(3): 114-122.
11. Wiendl H, Abicht A, Chan A, et al. Guideline for the management of myasthenic syndromes. Ther Adv Neurol Disord, 2023, 16: 71472968.
12. 羅蘇珊, 周昊, 岳耀先, 等. 重癥肌無力危象前狀態管理專家共識(2024). 中國臨床神經科學, 2024, 32(3): 241-251.Luo SS, Zhou H, Yue YX, et al. Expert consensus on the management of myasthenia gravis pre-crisis state (2024). Chin J Clin Neurosci, 2024, 32(3): 241-251.
13. 許雅芳, 薄琳, 邢介霞, 等. 成人全身型重癥肌無力患者全病程護理專家共識(2024). 中國臨床神經科學, 2024, 32(5): 577-586.Xu YF, Bo L, Xing JX, et al. Expert consensus on whole-course nursing for adult patients with generalized myasthenia gravis (2024). Chin J Clin Neurosci, 2024, 32(5): 577-586.
14. 中國醫師協會醫學機器人醫師分會胸外科專業委員會籌備組, 譚群友, 陶紹霖, 等. 機器人輔助縱隔腫瘤手術中國專家共識(2019版). 中國胸心血管外科臨床雜志, 2020, 27(2): 117-125.Thoracic Surgery Professional Committee Preparatory Group of Medical Robot Branch of Chinese Medical Doctor Association, Tan QY, Tao SL, et al. Chinese expert consensus on robot-assisted mediastinal tumor surgery (2019 edition). Chin J Clin Thorac Cardiovasc Surg, 2020, 27(2): 117-125.
15. Liu C, Liu P, Zhang XJ, et al. Assessment of the risks of a myasthenic crisis after thymectomy in patients with myasthenia gravis: a systematic review and meta-analysis of 25 studies. J Cardiothorac Surg, 2020, 15(1): 270.
16. 范沁琳, 袁馳, 靳英輝, 等. 基于RIGHT和ACCORD清單的專家共識規范化報告. 中國胸心血管外科臨床雜志, 2025, 32(7): 930-939.Fan QL, Yuan C, Jin YH, et al. Standardized reporting of expert consensus based on the RIGHT and ACCORD checklists. Chin J Clin Thorac Cardiovasc Surg, 2025, 32(7): 930-939.
17. Prado MJ, Adiao KJ. Acetylcholinesterase inhibitors in myasthenic crisis: a systematic review of observational studies. Neurocrit Care, 2021, 35(2): 528-544.
18. U?ak MN, Ar?t?c? ?G. Myasthenia gravis and nutrition. Front Nutr, 2025, 12: 1600508.
19. 王巖, 曹玉, 殷金環, 等. 胸腺瘤術后患者預后營養指數與總生存率的相關性. 腫瘤防治研究, 2021, 48(2): 140-144.Wang Y, Cao Y, Yin JH, et al. Correlation between prognostic nutritional index and overall survival rate in patients after thymoma surgery. Cancer Res Prev Treat, 2021, 48(2): 140-144.
20. Kondrup J, Allison SP, Elia M, et al. ESPEN guidelines for nutrition screening 2002. Clin Nutr, 2003, 22(4): 415-421.
21. 中華醫學會腸外腸內營養學分會. 成人圍手術期營養支持指南. 中華外科雜志, 2016, 54(9): 641-657.Chinese Society for Parenteral and Enteral Nutrition. Guidelines for nutritional support in the perioperative period for adults. Chin J Surg, 2016, 54(9): 641-657.
22. 陳梁. 免疫營養劑對胸腺瘤伴重癥肌無力術后并發癥的影響. 吉林大學, 2018.Chen L. The effect of immunonutritional agents on postoperative complications of thymoma with myasthenia gravis. Jilin University, 2018.
23. Probst P, Ohmann S, Klaiber U, et al. Meta-analysis of immunonutrition in major abdominal surgery. Br J Surg, 2017, 104(12): 1594-1608.
24. 邢娟, 章仲恒, 柯路, 等. 2017年中國ICU患者營養治療實施狀況橫斷面調查. 解放軍醫學雜志, 2019, 44(5): 388-393.Xing J, Zhang ZH, Ke L, et al. A cross-sectional survey on the implementation status of nutritional therapy for ICU patients in China in 2017. Med J Chin PLA, 2019, 44(5): 388-393.
25. Bolgeo T, Di Matteo R, Gallione C, et al. Intragastric prepyloric enteral nutrition, bolus vs continuous in the adult patient: a systematic review and meta-analysis. Nutr Clin Pract, 2022, 37(4): 762-772.
26. Wu JY, Liu MY, Liu TH, et al. Clinical efficacy of enteral nutrition feeding modalities in critically ill patients: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Nutr, 2023, 77(11): 1026-1033.
27. 賴敏華, 朱曼瑜, 林麗霞, 等. 重癥鼻飼病人防誤吸的最佳證據實踐研究. 循證護理, 2024, 10(15): 2666-2672.Lai MH, Zhu MY, Lin LX, et al. Best evidence practice study on preventing aspiration in severe nasal feeding patients. Chin Evid Based Nurs, 2024, 10(15): 2666-2672.
28. Hu K, Adachi JD. Glucocorticoid induced osteoporosis. Expert Rev Endocrinol Metab, 2019, 14(4): 259-266.
29. 張冰清, 曾學軍. 硫唑嘌呤相關白細胞減少的研究進展. 中華內科雜志, 2018, 57(7): 535-538.Zhang BQ, Zeng XJ. Research advances in azathioprine-associated leukopenia. Chin J Intern Med, 2018, 57(7): 535-538.
30. Venkataramanan R, Swaminathan A, Prasad T, et al. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet, 1995, 29(6): 404-430.
31. Abushammala I. Tacrolimus and herbs interactions: a review. Pharmazie, 2021, 76(10): 468-472.
32. 林良沫, 黃春新. 番石榴致環孢素血藥濃度升高患者的藥學監護. 中國醫院用藥評價與分析, 2015, 15(8): 1117-1119.Lin LM, Huang CX. Pharmaceutical care for a patient with elevated cyclosporine blood concentration due to guava. Chin J Drug Eval Anal, 2015, 15(8): 1117-1119.
33. Alipour-Faz A, Shojaei M, Peyvandi H, et al. A comparison between IVIG and plasma exchange as preparations before thymectomy in myasthenia gravis patients. Acta Neurol Belg, 2017, 117(1): 245-249.
34. Orbach H, Katz U, Sherer Y, et al. Intravenous immunoglobulin: adverse effects and safe administration. Clin Rev Allergy Immunol, 2005, 29(3): 173-184.
35. Imbach P, Barandun S, D'Apuzzo V, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet, 1981, 1(8232): 1228-1231.
36. Howard JJ, Bril V, Vu T, et al. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial. Lancet Neurol, 2021, 20(7): 526-536.
37. Ma J, Zhang H, Zhao J, et al. Efgartigimod versus intravenous immunoglobulin in the treatment of patients with impending myasthenic crisis. Sci Rep, 2024, 14(1): 28394.
38. 洪苗, 蔡東東, 魏彩輝, 等. 血漿置換治療胸腺瘤相關重癥肌無力的療效分析. 中國輸血雜志, 2025, 38(9): 1188-1194.Hong M, Cai DD, Wei CH, et al. Efficacy analysis of plasma exchange in the treatment of thymoma-associated myasthenia gravis. Chin J Blood Transfus, 2025, 38(9): 1188-1194.
39. Mahmoud SH, Buhler J, Chu E, et al. Drug dosing in patients undergoing therapeutic plasma exchange. Neurocrit Care, 2021, 34(1): 301-311.
40. 朱淑華, 龔德華. 血漿置換臨床實踐中的技術要點. 中國血液凈化, 2021, 20(5): 289-293.Zhu SH, Gong DH. Technical key points in the clinical practice of plasma exchange. Chin J Blood Purif, 2021, 20(5): 289-293.
41. Gashti CN, Andreoli DC, Patel D. Membrane-based therapeutic plasma exchange (mTPE): technical and clinical experience. J Clin Apher, 2018, 33(1): 38-45.
42. 戴兵, 曾力, 張雷, 等. 器官移植相關的血液凈化技術規范(2019版). 器官移植, 2020, 11(2): 208-221.Dai B, Zeng L, Zhang L, et al. Technical specifications for blood purification related to organ transplantation (2019 edition). Organ Transplant, 2020, 11(2): 208-221.
43. 程冰, 施文麗, 李晨陽, 等. 肝衰竭患者人工肝血漿置換護理的證據總結. 中國護理管理, 2025, 25(6): 901-907.Cheng B, Shi WL, Li CY, et al. Evidence summary for nursing care of liver failure patients undergoing artificial liver plasma exchange. Chin J Nurs Manag, 2025, 25(6): 901-907.
44. 徐萍, 于笑霞, 劉俊蘭. 198例雙重濾過血漿置換不良事件的安全性分析及護理對策. 風濕病與關節炎, 2014, 3(6): 32-34.Xu P, Yu XX, Liu JL. Safety analysis and nursing countermeasures for adverse events in 198 cases undergoing double filtration plasmapheresis. Rheumatism Arthritis, 2014, 3(6): 32-34.
45. 歐昶毅, 冉昊, 邱力, 等. 127例次重癥肌無力患者危象前狀態相關因素的分析. 中華醫學雜志, 2017, 97(37): 2884-2889.Ou CY, Ran H, Qiu L, et al. Analysis of related factors for pre-crisis state in 127 episodes of myasthenia gravis patients. Natl Med J China, 2017, 97(37): 2884-2889.
46. Chen P, Bao F, Pompeo E, et al. Summary of the best evidence for the prevention and management of myasthenic crisis after thymectomy. Gland Surg, 2024, 13(4): 540-551.
47. 曠振宇, 朱泉, 盧禮卿, 等. 胸腺切除治療重癥肌無力研究進展. 中國臨床新醫學, 2025, 18(10): 1080-1085.Kuang ZY, Zhu Q, Lu LQ, et al. Research progress in thymectomy for myasthenia gravis. Chin J Clin New Med, 2025, 18(10): 1080-1085.
48. Hoffacker V, Schultz A, Tiesinga JJ, et al. Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood, 2000, 96(12): 3872-3879.
49. 王振榮. 胸腺瘤術后肺部感染的危險因素分析與個體化護理. 遼寧醫學雜志, 2022, 36(5): 92-96.Wang ZR. Analysis of risk factors and individualized nursing for postoperative pulmonary infection in patients with thymoma. Med J Liaoning, 2022, 36(5): 92-96.
50. 韓丁培, 嚴越, 曹羽欽, 等. 加速康復外科理念在胸外科臨床實踐指導的瑞金醫院專家共識. 山東大學學報(醫學版), 2022, 60(11): 11-16.Han DP, Yan Y, Cao YQ, et al. Ruijin Hospital expert consensus on the guidance of enhanced recovery after surgery in thoracic surgery clinical practice. J Shandong Univ Health Sci, 2022, 60(11): 11-16.
51. Sheikh S, Alvi U, Soliven B, et al. Drugs that induce or cause deterioration of myasthenia gravis: an update. J Clin Med, 2021, 10(7): 1537.
52. 崔新征, 張清勇, 馬文強, 等. 快速康復外科在重癥肌無力外科治療中的應用. 中國實用神經疾病雜志, 2020, 23(5): 432-435.Cui XZ, Zhang QY, Ma WQ, et al. Application of enhanced recovery after surgery in the surgical treatment of myasthenia gravis. Chin J Pract Nerv Dis, 2020, 23(5): 432-435.
53. Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs, 2005, 14(7): 798-804.
54. Hawker GA, Mian S, Kendzerska T, et al. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken), 2011, 63(Suppl 11): S240-S252.
55. Castarlenas E, Sánchez-Rodríguez E, Vega RL, et al. Agreement between verbal and electronic versions of the numerical rating scale (NRS-11) when used to assess pain intensity in adolescents. Clin J Pain, 2015, 31(3): 229-234.
56. 王敏, 曾蘇華, 杜韞雨, 等. 護士驅動多學科協作下食管癌根治術病人圍術期疼痛管理方案的構建及應用. 護理研究, 2024, 38(20): 3715-3720.Wang M, Zeng SH, Du YY, et al. Construction and application of a perioperative pain management program for patients undergoing radical esophagectomy under nurse-led multidisciplinary collaboration. Chin Nurs Res, 2024, 38(20): 3715-3720.
57. Iorio R. Myasthenia gravis: the changing treatment landscape in the era of molecular therapies. Nat Rev Neurol, 2024, 20(2): 84-98.
58. Luo F, Annane D, Orlikowski D, et al. Invasive versus non-invasive ventilation for acute respiratory failure in neuromuscular disease and chest wall disorders. Cochrane Database Syst Rev, 2017, 12(12): D8380.
59. 劉蘭星, 康麗萍, 嚴玉英, 等. 重癥肌無力危象無創通氣應用的研究進展. 中華神經醫學雜志, 2021, 20(8): 859-863.Liu LX, Kang LP, Yan YY, et al. Research progress on the application of non-invasive ventilation in myasthenia gravis crisis. Chin J Neurol Med, 2021, 20(8): 859-863.
60. Munshi L, Mancebo J, Brochard LJ. Noninvasive respiratory support for adults with acute respiratory failure. N Engl J Med, 2022, 387(18): 1688-1698.
61. 羅蘇珊, 奚才華, 楊磊, 等. 重癥肌無力危象多學科協作的華山經驗. 中國臨床神經科學, 2023, 31(5): 550-557.Luo SS, Xi CH, Yang L, et al. The Huashan model of multidisciplinary collaboration for myasthenia gravis crisis. Chin J Clin Neurosci, 2023, 31(5): 550-557.
62. Sun Q, Shan F, Dong H, et al. Predictive value of ultrasonic diaphragm thickening fraction on successful weaning for patients with myasthenia gravis crisis. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2017, 29(7): 619-623.
63. Marois C, Combes A, Bouguerra M, et al. Weaning from mechanical ventilation in myasthenic crisis according to WEAN safe: most patients experience intermediate or prolonged weaning with no differences between early and late-onset compared to very-late onset myasthenia gravis. Ann Intensive Care, 2025, 15(1): 95.
64. 趙海平, 王榮榮. 神經重癥氣管切開患者氣道功能康復與管理專家共識(2024). 中國康復理論與實踐, 2024, 30(8): 869-881.Zhao HP, Wang RR. Expert consensus on airway function rehabilitation and management for tracheotomized patients with neurocritical illness (2024). Chin J Rehabil Theory Pract, 2024, 30(8): 869-881.
65. Lionello F, Lapia F, Molena B, et al. The safety of a high-flow nasal cannula in neuromuscular disease patients with acute respiratory failure: a retrospective case-series study. J Clin Med, 2023, 12(18): 6061.
66. 梁艷春, 蔡繼紅. 重癥肌無力患者癥狀負擔及心理體驗質性研究的Meta整合. 中華現代護理雜志, 2023, 29(27): 3662-3669.Liang YC, Cai JH. A meta-synthesis of qualitative research on symptom burden and psychological experience in patients with myasthenia gravis. Chin J Mod Nurs, 2023, 29(27): 3662-3669.
67. Luo S, Xiong Y, Song Z, et al. A cross-sectional study on fear of progression in patients with myasthenia gravis. Sci Rep, 2025, 15(1): 26181.
68. 王悅, 劉飛, 朱丹, 等. 乳腺癌患者同伴教育者總體幸福感現狀及影響因素研究. 中華護理雜志, 2024, 59(2): 191-197.Wang Y, Liu F, Zhu D, et al. Status and influencing factors of general well-being among peer educators in breast cancer patients. Chin J Nurs, 2024, 59(2): 191-197.
69. 邵紅濤, 任桂琴, 丁曉茜, 等. 正念冥想對走神的影響及其作用機制. 心理科學進展, 2023, 31(12): 2368-2379.Shao HT, Ren GQ, Ding XQ, et al. The influence of mindfulness meditation on mind wandering and its underlying mechanisms. Adv Psychol Sci, 2023, 31(12): 2368-2379.
70. Marvin S, Thibeault SL. Predictors of aspiration and silent aspiration in patients with new tracheostomy. Am J Speech Lang Pathol, 2021, 30(6): 2554-2560.
71. Benjapornlert P, Kagaya H, Inamoto Y, et al. The effect of reclining position on swallowing function in stroke patients with dysphagia. J Oral Rehabil, 2020, 47(9): 1120-1128.
72. 中國康復醫學會吞咽障礙康復專業委員會. 中國吞咽障礙康復管理指南(2023版). 中華物理醫學與康復雜志, 2023, 45(12): 1057-1072.Swallowing Disorders Rehabilitation Committee of Chinese Association of Rehabilitation Medicine. Chinese guidelines for rehabilitation management of swallowing disorders (2023 edition). Chin J Phys Med Rehabil, 2023, 45(12): 1057-1072.
73. Miao P, Zhang Y, Zhong A. Risk factors of aspiration occurrence with different feeding patterns in elderly intensive care unit patients: a cross-sectional study. J Thorac Dis, 2023, 15(5): 2585-2600.
74. 馬璐璐, 黃宇光. 胸腔鏡胸腺腫瘤切除術膈神經損傷導致低氧血癥: 2例病例報告和文獻綜述. 中華醫學雜志, 2020, 35(2): 191-194.Ma LL, Huang YG. Hypoxemia due to phrenic nerve injury after video-assisted thoracoscopic thymectomy: a case report of two patients and literature review. Chin Med Sci J, 2020, 35(2): 191-194.
75. 馮勇, 宋世源, 王林琳, 等. 胸腺瘤切除伴膈神經離斷后重癥肌無力危象前狀態診治一例. 中國臨床新醫學, 2025, 18(10): 1169-1171.Feng Y, Song SY, Wang LL, et al. Diagnosis and treatment of myasthenia gravis pre-crisis state after thymoma resection with phrenic nerve transection: a case report. Chin J Clin New Med, 2025, 18(10): 1169-1171.
76. 盧靜, 張永利. ICU危重癥患者膈肌功能障礙研究進展. 中國急救醫學, 2025, 45(2): 171-178.Lu J, Zhang YL. Research progress in diaphragmatic dysfunction in critically ill ICU patients. Chin J Crit Care Med, 2025, 45(2): 171-178.
77. Mendoza M, Tran C, Bril V, et al. Patient-acceptable symptom states in myasthenia gravis. Neurology, 2020, 95(12): e1617-e1628.
78. 皮紅英, 高遠, 候惠如, 等. 老年人跌倒風險綜合管理專家共識. 中華保健醫學雜志, 2022, 24(6): 439-441.Pi HY, Gao Y, Hou HR, et al. Expert consensus on comprehensive management of fall risk in older adults. Chin J Health Care Med, 2022, 24(6): 439-441.
79. Schoberer D, Breimaier HE, Zuschnegg J, et al. Fall prevention in hospitals and nursing homes: clinical practice guideline. Worldviews Evid Based Nurs, 2022, 19(2): 86-93.
80. 謝芳菲, 李雙玲, 王春梅. ICU危重患者靜脈血栓栓塞癥預防策略. 基礎醫學與臨床, 2024, 44(7): 906-911.Xie FF, Li SL, Wang CM. Prevention strategies for venous thromboembolism in critically ill ICU patients. Basic Clin Med, 2024, 44(7): 906-911.
81. 李夢婷, 楊華, 郭文進. 基于Caprini風險評估量表構建重癥監護病房患者深靜脈血栓形成的預測模型. 浙江臨床醫學, 2024, 26(7): 977-979.Li MT, Yang H, Guo WJ. Development of a prediction model for deep vein thrombosis in intensive care unit patients based on the Caprini risk assessment scale. Zhejiang Clin Med J, 2024, 26(7): 977-979.
82. 周鑫飛, 嚴靜. 靜脈血栓栓塞癥風險評估模型在重癥監護室中的應用. 心腦血管病防治, 2022, 22(6): 66-70.Zhou XF, Yan J. Application of venous thromboembolism risk assessment models in the intensive care unit. Prev Treat Card-Cereb Vasc Dis, 2022, 22(6): 66-70.
83. Corrado B, Giardulli B, Costa M. Evidence-based practice in rehabilitation of myasthenia gravis. A systematic review of the literature. J Funct Morphol Kinesiol, 2020, 5(4): 71.
84. 蔣琪霞, 劉國幀, 朱玉玲, 等. Braden量表診斷老年人壓力性損傷的適用性和最佳界值的多中心研究. 中華護理雜志, 2023, 58(4): 440-445.Jiang QX, Liu GZ, Zhu YL, et al. Applicability and optimal cutoff value of the Braden Scale for diagnosing pressure injury in older adults: a multicenter study. Chin J Nurs, 2023, 58(4): 440-445.
85. Tescher A, Deppisch M, Munro C, et al. Perioperative pressure injury prevention: National Pressure Injury Advisory Panel root cause analysis toolkit 3. 0. J Wound Care, 2022, 31(Sup12): S4-S9.
86. 劉鳴, 崔麗英, 謝鵬, 等. 神經內科學(第3版/研究生). 北京: 人民衛生出版社, 2021: 342.Liu M, Cui LY, Xie P, et al. Neurology (3rd ed., For Postgraduates). Beijing: People’s Medical Publishing House, 2021.
87. Wang S, Zhu M, Dong J, et al. Perioperative safety and efficacy of efgartigimod for thymoma-associated myasthenia gravis: a prospective, multicenter, phase II clinical trial. J Thorac Oncol, 2025, 20(8): 1120-1130.
88. 蔡崢, 丁曉璐, 郁雯佳. 靈芪參口服液聯合八段錦對脾腎氣虛證老年肌少癥患者的臨床療效. 中成藥, 2025, 47(8): 2822-2825.Cai Z, Ding XL, Yu WJ. Clinical efficacy of Lingqi Shen Oral Liquid combined with Baduanjin exercise on elderly patients with sarcopenia of spleen-kidney qi deficiency syndrome. Chin Tradit Pat Med, 2025, 47(8): 2822-2825.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Latest ArticlesExpert consensus on perioperative nursing care for myasthenia gravis patients undergoing thymectomy

Abstract Full text Figures/Tables Video References Cited by

Format

Content